top of page

Sanofi Genzyme starts phase 3 trial of second-generation enzyme replacement therapy for Pompe diseas

Sanofi Genzyme, the specialty care global business unit of Sanofi, has started a pivotal Phase 3 clinical trial named COMET for the investigational therapy neoGAA for Pompe Disease.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page